CLINICAL_TRIALS
trial_result
· 2013-10-01
Clinical Trial Update: The Effect of Xolair (Omalizumab) on Allergy Blood Cells [Phase 4]
Summary
Phase 4 trial update evaluating the effect of Xolair (omalizumab) on allergy-related blood cells in asthma patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Creighton University | Conditions: Asthma | Phase 4 | Status: COMPLETED